Renal Transplant Rejection
📧 Sign up to get email alerts when something new happens for Renal Transplant Rejection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-04-22Clinical Trial Update: Belimumab Impacting Transplant Eligibility [Phase 1, Phase 2]
Phase 1/2 trial evaluating belimumab and its impact on transplant eligibility in renal transplant rejection patients; study completed.
-
CLINICAL_TRIALS trial_result · 2018-08-22Clinical Trial Update: Efficacy of Rituximab in Acute Cellular Rejection in Renal Transplant Patients [Phase 3]
Phase 3 clinical trial evaluating rituximab for acute cellular rejection in renal transplant patients was terminated.
-
CLINICAL_TRIALS trial_result · 2018-03-06Clinical Trial Update: Testing Immunosuppression Threshold in Renal Allografts To Extend eGFR [NA]
A completed clinical trial evaluating whether adjusting immunosuppression thresholds in renal transplant recipients can extend estimated glo…
-
CLINICAL_TRIALS trial_result · 2017-08-10Clinical Trial Update: Diagnosis of Acute Rejection in Renal Transplant Patients by Urine Mass Spectrometry
This update reports on a clinical trial evaluating urine mass spectrometry as a diagnostic test for acute rejection in kidney transplant pat…
-
CLINICAL_TRIALS trial_result · 2017-06-27Clinical Trial Update: Imaging Kidney Transplant Rejection Using Ferumoxytol-Enhanced Magnetic Resonance [NA]
A Stanford-sponsored clinical trial evaluating ferumoxytol-enhanced MRI for imaging renal transplant rejection has completed and posted resu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-11-08Clinical Trial Update: To Elucidate the Effect of Mesenchymal Stem Cells on the T Cell Repertoire of the Kidney Transplant Patients [Phase 1]
A Phase 1 clinical trial evaluating the impact of mesenchymal stem cells on the T cell repertoire in renal transplant recipients.
-
CLINICAL_TRIALS trial_result · 2015-11-23Clinical Trial Update: Prospective Pilot Study of Pre-Transplant Thymoglobulin Administration in Living Donor Renal Transplant Recipients [Phase 4]
A Phase 4 pilot study evaluating pre-transplant thymoglobulin to prevent rejection in living-donor kidney transplant recipients has complete…
-
CLINICAL_TRIALS trial_result · 2015-10-20Clinical Trial Update: A Trial Comparing Prograf and Neoral Use in Kidney Transplant Recipients of Hispanic Ethnicity [Phase 4]
Phase 4 trial comparing tacrolimus (Prograf) and cyclosporine (Neoral) in kidney transplant recipients; the study was terminated and results…
-
CLINICAL_TRIALS research · 2015-07-03Clinical Trial Update: A Perspective Multicenter Controlled Study On Application Of Mesenchymal Stem Cell(MSC) To Prevent Rejection After Renal Transplantation By Donation After Cardiac Death [Phase 1]
Phase 1 multicenter study evaluating whether mesenchymal stem cells can prevent rejection after kidney transplantation from donation after c…
-
CLINICAL_TRIALS trial_result · 2015-05-01Clinical Trial Update: Efficacy and Safety of ATG-Fresenius Following a Renal Transplantation, Without Corticosteroids [Phase 3]
Phase 3 trial of ATG-Fresenius after renal transplantation without corticosteroids was terminated. The update reports on the efficacy and sa…
-
CLINICAL_TRIALS trial_result · 2015-03-18Clinical Trial Update: A Study to Evaluate the Effect of Thymoglobulin and Reduced Doses of Steroids to Prevent Renal Transplant Rejection [Phase 2]
Phase 2 study evaluating thymoglobulin with reduced steroid doses to prevent rejection in kidney transplant recipients; study completed.
-
CLINICAL_TRIALS trial_result · 2014-11-14Clinical Trial Update: Calcineurin Activity in Renal Recipients [Phase 4]
Phase 4 clinical trial evaluating calcineurin activity in renal transplant recipients with rejection has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-03-26Clinical Trial Update: The Effect of Rituximab on the Development of Anti-Donor Antibodies [NA]
A completed clinical trial evaluated whether rituximab affects the development of anti-donor antibodies in renal transplant rejection. Resul…
-
CLINICAL_TRIALS trial_result · 2012-02-16Clinical Trial Update: Renal Function Evaluation After Reduction of Cyclosporine A Dose in Renal Transplant Patients [Phase 3]
This Phase 3 trial evaluated renal function after reducing the dose of cyclosporine A in renal transplant recipients and has completed.
-
CLINICAL_TRIALS trial_result · 2011-03-08Clinical Trial Update: Induction Therapy With Autologous Mesenchymal Stem Cells for Kidney Allografts [NA]
Clinical trial assessing induction therapy with autologous mesenchymal stem cells for kidney allografts has completed.
-
FDA label_change · 2009-01-29FDA Approved: SIROLIMUS — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Sirolimus from Mylan Pharmaceuticals Inc., resulting in labeling updates for the product.
-
CLINICAL_TRIALS trial_result · 2007-05-10Clinical Trial Update: Th1, Th2 and Monokine Responses as Risk Factors of Renal Transplant Rejection
This clinical trial update examines how Th1/Th2 balance and monokine responses may influence the risk of renal transplant rejection.